Are Adrenal Supplements Safe? The Cortisol-Spiking Risk Most Labels Hide

No, adrenal supplements are not reliably safe. Most sold in the United States are unapproved dietary supplements, not drugs, so they reach shelves without FDA proof of safety or efficacy, and a minority contain undisclosed hormones or steroid-like compounds that can suppress the body's own cortisol production. The bigger everyday danger is indirect: these products are marketed to people who are actually sick with adrenal insufficiency or thyroid disease, and the pills can delay real diagnosis by months. For a healthy person, risk is usually low but not zero. For anyone with fatigue of unknown cause, the question is not "are they safe" but "is this even the right problem."

What adrenal supplements contain, and what they claim to do

The category is loose. "Adrenal support" products typically bundle three kinds of ingredients: adaptogenic herbs such as ashwagandha, rhodiola, and ginseng; glandular extracts made from bovine or porcine adrenal tissue; and micronutrients like vitamin C, B5, and magnesium, which the adrenal cortex uses to manufacture cortisol. Dosages vary enormously between brands and even between lots of the same brand, because supplement manufacturing is held to food-grade standards, not pharmaceutical ones.

The marketing premise is "adrenal fatigue," a term that has no accepted medical definition and is not a recognized diagnosis in endocrinology. It describes a constellation of ordinary symptoms: tiredness, low morning energy, salt cravings, brain fog, and feeling "wired but tired." Those symptoms overlap heavily with sleep apnea, depression, anemia, thyroid dysfunction, and genuine adrenal insufficiency, which is why the label matters clinically. A 2016 systematic review by Cadegiani and Kater found no consistent evidence validating the syndrome. That does not mean patients feel fine. It means the explanation and the treatment being sold alongside it are not established.

In plain terms: the products are built around a diagnosis that mainstream medicine rejects, and the ingredients are mostly unregulated herbals.

The mechanism: how cortisol regulation actually works

Cortisol is the end product of a three-layer feedback loop. The hypothalamus releases corticotropin-releasing hormone (CRH), which signals the pituitary to release adrenocorticotropic hormone (ACTH), which tells the adrenal cortex to make cortisol. Rising cortisol then feeds back to shut down CRH and ACTH. Total daily cortisol output in a healthy adult averages roughly 15 to 25 mg, peaking 30 to 45 minutes after waking and falling to its nadir around midnight.

That feedback loop is the reason glandular adrenal extracts are risky. If a product delivers meaningful exogenous cortisol or a steroid that binds the same receptor, the pituitary reads the surplus and cuts ACTH. The adrenal glands, no longer stimulated, atrophy. Stop the product abruptly and the body cannot produce enough cortisol on its own. This is the same mechanism behind adrenal suppression from prescription prednisone, which can occur at doses of 5 mg daily for as little as two to four weeks and requires a taper.

Adaptogens work through a different, weaker route. Ashwagandha and rhodiola appear to modulate the HPA axis at the hypothalamic level and may blunt the cortisol awakening response by a modest margin in stressed adults, but doses, extracts, and standardization differ so much that one product's results do not transfer to another. This is a plausible mechanism, not a settled one, and effect sizes in trials are small.

Licorice root deserves separate mention. It inhibits 11-beta-hydroxysteroid dehydrogenase type 2, the enzyme that converts cortisol to inactive cortisone in the kidney. Inhibition lets cortisol flood the mineralocorticoid receptor, producing sodium retention, potassium loss, and blood pressure elevation. The effect is real and dose-dependent, and it can mimic primary hyperaldosteronism on lab testing.

How many products are actually mislabeled

Quantified context matters here, because "supplements are unregulated" is vague. The FDA's own testing has found that a substantial share of tainted products contain undeclared pharmaceutical ingredients, and its tainted supplement database logs hundreds of products per year across categories. For adrenal and "hormone support" products specifically, independent analyses have detected androstenedione-like steroids and synthetic glucocorticoids in a minority of glandular preparations. The precise percentage is not known, because no agency routinely screens this category.

A landmark analysis of botanical supplements by Newmaster and colleagues in 2013 found that roughly 59 percent of tested plant products contained DNA from species not listed on the label, including fillers and contaminants. That study covered herbal products broadly, not adrenal pills alone, but it establishes the baseline problem: what is on the label is not guaranteed to be what is in the bottle.

The comparison that matters is against prescription therapy. For confirmed adrenal insufficiency, hydrocortisone replacement is dosed in precise milligrams, monitored with ACTH stimulation testing, and adjusted during illness. There is no supplement that replicates that rigor.

Who is genuinely at risk

Risk is not evenly distributed. Three groups carry most of the danger. People with undiagnosed or diagnosed adrenal insufficiency can be pushed into crisis by a product that interferes with cortisol signaling or by the false reassurance that they are "supporting" their glands. People taking prescription corticosteroids, whether for asthma, arthritis, or inflammatory bowel disease, face additive suppression if a glandular extract adds steroid load. And people with hypertension or kidney disease can be tipped by licorice-containing formulas, where potassium losses and sodium retention raise blood pressure within weeks.

Pregnant and breastfeeding people are a fourth edge case. Ashwagandha has been linked in animal data to effects on thyroid hormone and uterine tissue, and there is no adequate human safety data in pregnancy. The FDA does not require pregnancy warnings on most supplement labels, so absence of a warning is not evidence of safety.

A subtler risk is diagnostic delay. The classic presentation of Addison's disease, with fatigue, salt craving, and hyperpigmentation, can take months to diagnose even without supplements. A patient who self-treats for a year may arrive at an endocrinologist already in incipient crisis, with low sodium, high potassium, and a cortisol level too low to interpret cleanly.

The "natural means safe" misconception and other myths

The most expensive misconception is that botanical equals benign. Herbal products cause liver injury, drug interactions, and blood pressure effects at real rates. The Drug-Induced Liver Injury Network has identified herbal and dietary supplements as a rising share of acute liver injury cases in the United States, now accounting for roughly 20 percent of reported cases in some series. Ashwagandha has been implicated in a small number of documented hepatotoxicity cases, typically resolving after discontinuation.

A second myth is that a low salivary cortisol proves "adrenal fatigue." Salivary testing is highly variable, poorly standardized across labs, and easily distorted by collection timing and oral contamination. A low afternoon salivary value in an exhausted person is not diagnostic of anything; the accepted test for adrenal insufficiency is a morning serum cortisol plus an ACTH stimulation test, interpreted against published thresholds.

A third is that glandular extracts are homeopathic and therefore inert. Some are dosed high enough to contain measurable hormone. A product labeled as "adrenal concentrate" at several hundred milligrams is not the same as a 6X dilution.

What to actually do

If you suspect your adrenals are the problem, the productive first step is a medical one, not a purchase. Ask for a morning cortisol drawn between 8 and 9 a.m., a basic metabolic panel to check sodium and potassium, and, if clinically indicated, an ACTH stimulation test. These are inexpensive and definitive in a way no supplement can be.

If you have already been cleared and still want to try an adaptogen, treat it like a drug trial: one product at a time, a standardized extract with the active compound percentage printed on the label, a fixed dose, and a written log of symptoms over eight weeks. Stop if you develop palpitations, unusual swelling, dark urine, or yellowing of the eyes.

Read every label for licorice root, glycyrrhiza, and "adrenal extract." If you take a corticosteroid, a blood pressure medication, or a thyroid hormone, check with a pharmacist before adding anything, because interactions are common and under-studied. And tell your clinician what you are taking, including dose and brand, because that information changes how your labs are read.

• Red flags that mean stop and seek care: blood pressure above 160/100, new palpitations, swelling in the legs, dark or tea-colored urine, yellowing skin or eyes, severe weakness with vomiting, or fainting on standing.

Timeline: what happens if you take them, and if you stop

The time course depends entirely on what is in the pill. Herbal adaptogens build effects over weeks; glandular extracts with steroid content can suppress the HPA axis within days to weeks and unmask on withdrawal.

Limitations of the evidence

Honesty about what is unknown is part of safety. There are no large randomized trials of adrenal supplement products as sold, because the products are not standardized and no manufacturer has funded one. Most adaptogen trials enroll 40 to 80 stressed but healthy adults for 8 to 12 weeks, which is too short and too small to detect rare harms. The long-term safety data simply does not exist.

The tainted-product rate is also a moving target. The FDA's enforcement is reactive, triggered by adverse event reports, so the true prevalence of adulteration in this niche is likely higher than any published figure. And "adrenal fatigue" remains a contested label, meaning some patients are told they have a condition and treated for it before the underlying thyroid, sleep, or mood disorder is ever identified.

In plain terms: absence of evidence of harm is not evidence of safety, especially for a product category nobody is required to study. The safest stance for a healthy person is skepticism; the safest stance for a sick one is a doctor's visit first.